Changeflow GovPing Healthcare & Life Sciences ANSM Safety Recall: Autoimmunity IDS SS-A/Ro Re...
Priority review Notice Removed Final

ANSM Safety Recall: Autoimmunity IDS SS-A/Ro Reagent

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published
Detected
Email

Summary

The French ANSM has issued a safety recall (R2532493) for a specific lot of the Autoimmunity IDS SS-A/Ro reagent manufactured by Immunodiagnostic Systems (IDS). Laboratories using this reagent have been notified directly by the manufacturer.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The French National Agency for Medicines and Health Products Safety (ANSM) has announced a safety recall, registered under number R2532493, concerning a specific lot of the Autoimmunity IDS SS-A/Ro reagent from Immunodiagnostic Systems (IDS). This action is a product recall, indicating a potential safety issue or defect with the reagent.

Laboratories that have received the affected reagent lot must take immediate action as directed by Immunodiagnostic Systems (IDS). While the ANSM directs inquiries to the manufacturer, affected entities should consult the provided letter from IDS dated March 17, 2026, for specific instructions on handling the recalled product, which may include returning or discarding the reagent. Failure to comply with recall procedures could have implications for patient safety and laboratory accreditation.

What to do next

  1. Review correspondence from Immunodiagnostic Systems (IDS) regarding recall R2532493.
  2. Implement necessary actions for the affected lot of Autoimmunity IDS SS-A/Ro reagent as instructed by IDS.
  3. Contact Immunodiagnostic Systems (IDS) directly for any questions or clarification.

Archived snapshot

Mar 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information de rappel n° R2532493 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre du retrait d’un lot effectué par la société Immunodiagnostic Systems (IDS).
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2532493.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Immunodiagnostic Systems (IDS) (17/03/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Published
March 17th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers
Geographic scope
France France

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Product Safety Medical Devices

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!